PEB · ASX

Pacific Edge Limited (ASX:PEB)

AU$0.098

 0.0 (0.0%)
ASX:Live
18/07/2025 09:59:13 AM
HALO Price Momentum HALO Ords GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

PEB Overview

PEB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About PEB

Website

N/A

Telephone

64.3.479.5800

Address

87 St. David Street Centre for Innovation Dunedin, Otago 9016

Description

Pacific Edge Ltd. engages in the provision of discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. It operates in the Commercial and Research segments. The Commercial segment involves the sales, marketing, laboratory, and support to run the commercial businesses worldwide. The Research segment engages in the research and development of diagnostic and prognostic products for human cancer. The company was founded on February 27, 2001 and is headquartered in Dunedin, New Zealand.

PEB Price Chart

Key Stats

Market Cap

AU$78.35M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.05 - 0.18

Trade Value (12mth)

AU$674.00

1 week

1.03%

1 month

20.99%

YTD

-27.41%

1 year

27.27%

All time high

1.61

Key Fundamentals

EPS 3 yr Growth

38.30%

EBITDA Margin

-136.90%

Operating Cashflow

-$23m

Free Cash Flow Return

-58.40%

ROIC

-70.60%

Interest Coverage

-854.70

Quick Ratio

3.00

Other Data

Shares on Issue (Fully Dilluted)

812m

HALO Sector

Healthcare

Next Company Report Date

27-May-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.13

PEB Announcements

Latest Announcements

Date Announcements

17 July 25

Pacific Edge Opens $5.0 Million Share Purchase Plan

×

Pacific Edge Opens $5.0 Million Share Purchase Plan

17 July 25

Notice of Annual Shareholders' Meeting

×

Notice of Annual Shareholders' Meeting

17 July 25

Appendix 3B - Proposed Issue of Securities - SPP

×

Appendix 3B - Proposed Issue of Securities - SPP

17 July 25

Proposed issue of securities - PEB

×

Proposed issue of securities - PEB

17 July 25

Proposed issue of securities - PEB

×

Proposed issue of securities - PEB

17 July 25

Cancel - Proposed issue of securities - PEB

×

Cancel - Proposed issue of securities - PEB

16 July 25

Pacific Edge - Cleansing Notice

×

Pacific Edge - Cleansing Notice

14 July 25

Q1 26 Cxbladder Demand Resilient Despite Coverage Loss

×

Q1 26 Cxbladder Demand Resilient Despite Coverage Loss

30 June 25

Annual Report 2025

×

Annual Report 2025

16 June 25

Letter to Shareholders

×

Letter to Shareholders

03 June 25

Pacific Edge Placement Upsized to NZ$16 Million

×

Pacific Edge Placement Upsized to NZ$16 Million

30 May 25

Trading Halt

×

Trading Halt

30 May 25

Proposed issue of securities - PEB

×

Proposed issue of securities - PEB

30 May 25

Pacific Edge Launches NZ $20m Capital Raise

×

Pacific Edge Launches NZ $20m Capital Raise

30 May 25

Pacific Edge Reports Resilient Performance in FY25

×

Pacific Edge Reports Resilient Performance in FY25

12 May 25

Pacific Edge FY25 Result to be Announced 30 May 2025

×

Pacific Edge FY25 Result to be Announced 30 May 2025

29 April 25

Triage Plus Set to Lift Pacific Edge's Economics

×

Triage Plus Set to Lift Pacific Edge's Economics

29 April 25

Pause in Trading

×

Pause in Trading

28 April 25

Medicare LCD Effective - Pacific Edge Seeks Recoverage

×

Medicare LCD Effective - Pacific Edge Seeks Recoverage

24 April 25

US COURT LACKS JURISDICTION TO HEAR PACIFIC EDGE CLAIM

×

US COURT LACKS JURISDICTION TO HEAR PACIFIC EDGE CLAIM

04 April 25

Q4 25 Cxbladder Volumes Rise and Key Metrics Improve

×

Q4 25 Cxbladder Volumes Rise and Key Metrics Improve

28 February 25

Cxbladder Incorporated into AUA Clinical Guideline

×

Cxbladder Incorporated into AUA Clinical Guideline

28 January 25

Ongoing Disclosure Notice

×

Ongoing Disclosure Notice

28 January 25

Medicare LCD Effective Date Extended to 24 April 2025

×

Medicare LCD Effective Date Extended to 24 April 2025

22 January 25

Pacific Edge Release Quarterly Volumes for Q3 FY25

×

Pacific Edge Release Quarterly Volumes for Q3 FY25

PEB Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.03 -0.03 -0.03 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.03 -0.03 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock -24.7 -11.6 0.6 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.03 -0.03 -0.03 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.03 -0.03 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock -31.1 -11.4 1.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock -7.7 -39.0 -24.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.10 0.06 0.03 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.09 0.06 0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock -23.7 -35.6 -53.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 810 811 812 Lock Lock Lock
Basic m Lock Lock Lock Lock 810 811 812 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Income Statement
Sales $m Lock Lock Lock Lock 18 22 20 Lock Lock Lock
     Growth % Lock Lock Lock Lock 65.7 24.0 -10.3 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 39 43 37 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 9 10 8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 103.5 19.6 -26.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 49.0 47.2 38.7 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 51 53 61 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -29 -30 -27 Lock Lock Lock
     Growth % Lock Lock Lock Lock -46.2 -4.9 9.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -159.7 -135.1 -136.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 2 2 3 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -30 -32 -30 Lock Lock Lock
     Growth % Lock Lock Lock Lock -45.7 -6.1 8.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -170.6 -146.0 -149.6 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -26 -29 -28 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -25 -27 -27 Lock Lock Lock
     Growth % Lock Lock Lock Lock -31.7 -11.4 0.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -137.5 -123.5 -137.0 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -23 -24 -23 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 3 1 1 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 20 21 6 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -25 -25 -23 Lock Lock Lock
     Growth % Lock Lock Lock Lock -45.2 1.5 5.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1.4 -1.1 -1.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 73 46 21 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 85 60 34 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 2 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -72 -42 -18 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 8 10 10 Lock Lock Lock
Equity $m Lock Lock Lock Lock 77 50 24 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 78 52 25 Lock Lock Lock
     Growth % Lock Lock Lock Lock -23.2 -32.6 -52.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -28.9 -45.6 -81.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -31.8 -54.7 -114.9 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -33.8 -48.9 -74.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -27.5 -42.1 -70.6 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -26.1 -36.7 -58.4 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Leverage
Interest Cover X Lock Lock Lock Lock -2,409.8 -1,537.9 -854.7 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.5 1.4 0.7 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -92.5 -84.6 -75.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 11.1 7.0 3.2 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 10.9 6.8 3.0 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 90.5 86.8 73.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -322.3 -313.0 -254.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 4.0 4.7 4.5 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 8.5 8.5 8.1 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.2 0.5 1.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 11.4 8.9 12.1 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.2 0.4 0.6 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.2 0.4 0.6 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -144.5 -129.0 -141.1 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -30.4 -47.6 -83.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -28.9 -45.6 -81.0 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.2 1.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -31.8 -54.7 -114.9 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -31.8 -54.7 -114.9 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 42.7 42.9 45.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 90.3 77.7 81.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 133.1 120.6 126.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 73.8 60.8 65.9 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 59.2 59.9 60.1 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.13%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

PEB Shortsell

Frequently Asked Questions

The current share price of Pacific Edge Limited (PEB:ASX) is AU$0.098.
The 52-week high share price for Pacific Edge Limited (PEB:ASX) is AU$0.18.
The 52-week low share price for Pacific Edge Limited (PEB:ASX)? is AU$0.05.
Pacific Edge Limited (PEB:ASX) does not pay a dividend.
Pacific Edge Limited (PEB:ASX) does not pay a dividend.
Pacific Edge Limited (PEB:ASX) has a franking level of 0.0%.
Pacific Edge Limited (PEB:ASX) is classified in the Healthcare.
The current P/E ratio for Pacific Edge Limited (PEB:ASX) is .
The current share price of Pacific Edge Limited (PEB:ASX) is AU$0.098.
The 52-week high share price for Pacific Edge Limited (PEB:ASX) is AU$0.18.
The 52-week low share price for Pacific Edge Limited (PEB:ASX)? is AU$0.05.
Pacific Edge Limited (PEB:ASX) does not pay a dividend.
Pacific Edge Limited (PEB:ASX) does not pay a dividend.
Pacific Edge Limited (PEB:ASX) has a franking level of 0.0%.
Pacific Edge Limited (PEB:ASX) is classified in the Healthcare.
The current P/E ratio for Pacific Edge Limited (PEB:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.